Activity of single-agent PD-1 inhibitor (PD-1i) therapy in advanced sarcoma: A single-center retrospective analysis.

e23541Background: Sarcomas constitute a heterogeneous group of mesenchymal tumors with variable responses to traditional chemotherapies. Recent PD-1i immunotherapy studies show promising results wi...